Home
Home » Monthly archive

June 2012

Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy

Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy
Pipeline Review

Salix Pharma: What's The Buzz?

Salix Pharma: What's The Buzz?
RTT News

Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma

Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma
Pharmabiz

Noven Pharmaceuticals provides update on status of generic Lidoderm ANDA

Noven Pharmaceuticals provides update on status of generic Lidoderm ANDA
news-medical.net

Biogen Idec Inc. and Isis Pharmaceuticals Inc. to Work Together in a Project

Biogen Idec Inc. and Isis Pharmaceuticals Inc. to Work Together in a Project
French Tribune, France

K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria

K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria
MarketWatch

Why Biotechs Arena And Vivus Will Grow While People Shrink

Why Biotechs Arena And Vivus Will Grow While People Shrink
Seeking Alpha

Pfizer takes Alembic to US court on drug patent

Pfizer takes Alembic to US court on drug patent
Business Standard, India

AstraZeneca hungry to refill medicine cabinet

AstraZeneca hungry to refill medicine cabinet
Yahoo/Reuters

The World's Best Innovation That Isn't Worth Investing In

The World's Best Innovation That Isn't Worth Investing In
Motley Fool